Entries by Dana Fowlkes

The Beginninng of the End of the Pandemic Era

The global scientific and technical response to the Covid-19 pandemic illustrates the power of 21st century medical science and technology.  Clearly, a goal, based upon that we’ve learned, can be and should be the elimination of future pandemics.  While Evrys Bio’s daily work is on the development of  therapeutics for a broad range of viral […]

Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool

Amesh Adaljaa of the Center for Health Security, Johns Hopkins Bloomberg School of Public Health and Thomas Inglesby of the Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA wrote a editorial in EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019, VOL. 17, NO. 7, 467–470) spelling out the need […]

Gov. Wolf awards $1.1 million to biotech center in Buckingham for COVID-19 work

Pennsylvania Biotechnology Center of Bucks County is once again in the spotlight, this time as the recipient of more than $1 million in state grants to help with research in pursuing a treatment and vaccine for COVID-19. Of 23 state awards, the biotechnology center, located next to the Doylestown Airport in Buckingham, received four grants, bringing in $1.1 million […]

Pennsylvania Awards $10 Million to 23 Entities

Governor Tom Wolf announced that 23 awardees will receive $10 million in grant funding through the COVID-19 Vaccines, Treatments and Therapies (CV-VTT) program to support the rapid advancement of vaccines, treatments and therapies by qualified biotechnology entities in response to the COVID-19 pandemic. Evrys Bio was awarded over $300,000 to develop treatments for virus caused […]

November 21, 2019 – Evrys Bio President & CEO, Lillian Chiang gives oral presentation, “Host Sirtuin-2 Protein (SIRT2) – A Validated Target for Broadly-Effective Antiviral Small-Molecule Drugs”

November 21, 2019 – Evrys Bio President & CEO, Lillian Chiang gives oral presentation, “Host Sirtuin-2 Protein (SIRT2) – A Validated Target for Broadly-Effective Antiviral Small-Molecule Drugs,” at the 2019 Chemical and Biological Defense Science & Technology (CBD S&T) Conference Cincinnati, OH.   See the PowerPoint Presentation